Page last updated: 2024-08-21

alpha-aminopyridine and Blood Poisoning

alpha-aminopyridine has been researched along with Blood Poisoning in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (40.00)24.3611
2020's6 (60.00)2.80

Authors

AuthorsStudies
Anthony, S; Bajaj, A; Bhundia, V; Branson, A; Brookes, C; Darlison, L; Dawson, AG; Fennell, DA; Gaba, A; Greystoke, A; Hutka, M; King, A; Mohammed, S; Morgan, B; Nusrat, N; Poile, C; Richards, C; Scotland, M; Thomas, A; Wells-Jordan, P1
Gong, X; Jia, J; Li, G; Wang, Q1
Hu, B; Jiang, H; Liao, L; Tan, M; Xu, X1
Chancharoenthana, W; Issara-Amphorn, J; Leelahavanichkul, A; Visitchanakun, P1
Bayraktutan, Z; Bilen, A; Dincer, B; Halici, Z; Keskin, H; Kose, D; Sirin, B; Toktay, E1
Gupta, K; Kumari, A; Pandey, S; Sen, P; Singh, G; Singh, R1
Chen, J; Cheng, Y; Feng, H; Wang, H; Xu, J; Zhong, Q; Zou, Z1
Chang, X; Hu, LF; Li, JB; Liu, XY; Ma, XJ; Yin, J1
Colgan, SP; Eckle, T; Eltzschig, HK; Hartmann, K; Macmanus, CF; Schingnitz, U; Zug, S1
Bryant, JW; Gibson, GW; Kolte, D; Shariat-Madar, Z; Wang, J1

Trials

1 trial(s) available for alpha-aminopyridine and Blood Poisoning

ArticleYear
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
    The Lancet. Oncology, 2022, Volume: 23, Issue:3

    Topics: Alanine Transaminase; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Diarrhea; Hemoptysis; Humans; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Pulmonary Embolism; Respiratory Tract Infections; Sepsis; Thrombocytopenia; Vomiting

2022

Other Studies

9 other study(ies) available for alpha-aminopyridine and Blood Poisoning

ArticleYear
[Protective effect and mechanism of Ribociclib on sepsis induced-acute kidney injury].
    Zhonghua wei zhong bing ji jiu yi xue, 2020, Volume: 32, Issue:2

    Topics: Acute Kidney Injury; Aminopyridines; Animals; Male; Mice; Mice, Inbred C57BL; Protective Agents; Purines; Sepsis; Tumor Necrosis Factor-alpha

2020
Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.
    Medical science monitor : international medical journal of experimental and clinical research, 2020, May-25, Volume: 26

    Topics: Acute Kidney Injury; Aminopyridines; Animals; Apoptosis; Benzamides; Blood Urea Nitrogen; Creatinine; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Cytokines; Female; Hepatitis A Virus Cellular Receptor 1; Inflammation; Kidney; Lipocalin-2; Mice; Mice, Inbred BALB C; NF-kappa B; Phosphodiesterase 4 Inhibitors; Sepsis

2020
Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis.
    Journal of innate immunity, 2020, Volume: 12, Issue:6

    Topics: Aminopyridines; Animals; Cells, Cultured; Coinfection; Disease Models, Animal; Humans; Inflammation Mediators; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Oxazines; Pyridines; Pyrimidines; Receptors, IgG; Sepsis; Signal Transduction; Syk Kinase

2020
Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2022, Volume: 35, Issue:3

    Topics: Aminopyridines; Animals; Benzamides; Cecum; Cyclopropanes; Disease Models, Animal; Ligation; Lung; Lung Injury; NF-kappa B; Punctures; Rats; Sepsis

2022
Roflumilast improves resolution of sepsis-induced acute kidney injury by retarding late phase renal interstitial immune cells infiltration and leakage in urinary sediments.
    Fundamental & clinical pharmacology, 2022, Volume: 36, Issue:1

    Topics: Acute Kidney Injury; Aminopyridines; Animals; Benzamides; Cyclopropanes; Disease Models, Animal; Kidney; Rats; Sepsis

2022
Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.
    Laboratory investigation; a journal of technical methods and pathology, 2017, Volume: 97, Issue:9

    Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Bacterial Load; Benzamides; Cyclopropanes; Cytokines; Inflammation; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Sepsis; STAT3 Transcription Factor; Survival Analysis

2017
Influence of roflumilast on sepsis mice through the JAK/STAT signaling pathway.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:3

    Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Female; Janus Kinases; Lung; Male; Mice; Phosphodiesterase 4 Inhibitors; Sepsis; Signal Transduction; STAT3 Transcription Factor

2019
Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury.
    Journal of immunology (Baltimore, Md. : 1950), 2010, May-01, Volume: 184, Issue:9

    Topics: Acetamides; Acute Lung Injury; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Administration, Inhalation; Aminopyridines; Animals; Bone Marrow Transplantation; Cell Line; Cell Line, Tumor; Disease Models, Animal; Humans; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Purines; Receptor, Adenosine A2B; Sepsis; Signal Transduction

2010
PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.
    Cardiovascular & hematological agents in medicinal chemistry, 2012, Volume: 10, Issue:2

    Topics: Aminobenzoates; Aminopyridines; Animals; Blood Coagulation; Disease Models, Animal; Disseminated Intravascular Coagulation; Dose-Response Relationship, Drug; Inflammation Mediators; Lipopolysaccharides; Male; Plasma Kallikrein; Rabbits; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Sepsis; Thrombosis

2012